Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Goes Fishing for Molecular Dx Future With Siemens

NEW YORK, Oct. 19 (GenomeWeb News) - Siemens, the giant German medical-systems manufacturer, will buy four Sequenom MassArray platforms as part of a broader collaboration to develop new molecular diagnostics platforms, Sequenom said today.


"We are interested in novel platforms for different nucleic acid based diagnostic applications," Mohammad Naraghi, senior vice president of business development at Siemens Medical Solutions, said in a statement. He said the MassArray technology "may be a good foundation" for the molecular diagnostics market.


As part of a "joint working group" the companies created for this collaboration, Siemens will install the four systems in certain diagnostics and clinical labs in Europeand North America, where Sequenom and Siemens will "execute a comprehensive functional requirement analysis," Sequenom said.


"There is a huge potential for innovation in diagnostics and IT systems," Erich Reinhardt, president and CEO of Siemens Medical Solutions, said in the statement. "Molecular medicine will have a significant impact on these platform developments."


Financial details of the collaboration were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.